Tracking with body scans, tape measures or strength tests can help you see what works
These cost more but provide the holistic approach that research shows produces better long-term outcomes
Rare but serious side effects may include pancreatitis, hypoglycemia, gallbladder problems, allergic reactions, kidney failure, and changes in vision
At this time, it is uncertain how participating beneficiaries will be able to maintain Medicare coverage of their GLP-1 medication for obesity after the Medicare GLP-1 Bridge ends at the end of 2027, pending further action from CMS to implement the BALANCE Model in Medicare Part D in 2028, as described below
Cost & insurance coverage The cost difference between these medications is dramatic
Insurance covers GLP-1 medications, but coverage extent varies by your provider, location, and health circumstances